Background. Monovalent rotavirus vaccine was introduced in the routine public health
immunization program in Lusaka, Zambia, in January 2012 and was rolled out countrywide in …

Developing a broadly protective vaccine covering most ETEC variants has been elusive. The
most clinically advanced candidate yet is an oral inactivated ETEC vaccine (ETVAX ® ). We …

Background Enterotoxigenic Escherichia coli (ETEC) is an important cause of moderate to
severe diarrhoea in children for which there is no licensed vaccine. We evaluated ETVAX®, …

Introduction The re-emergence of vector borne diseases affecting millions of people in
recent years has drawn attention to arboviruses globally. Here, we report on the sero-prevalence …

Diarrhoea is a major contributor to childhood morbidity and mortality in developing countries,
with diarrhoeagenic Escherichia coli being among the top aetiological agents. We sought …

Oral rotavirus vaccines show diminished immunogenicity in low-resource settings where
rotavirus burden is highest. This study assessed the safety and immune boosting effect of a …

Diarrhoeagenic E. coli (DEC) significantly contributes to the burden of diarrhoea among
children. Currently, there is no approved vaccine against DEC, but several vaccines against the …

… We also thank Cynthia Phiri Mubanga and Sekayi Tigere for the technical lab support and
all other CIDRZ Enteric Diseases and Vaccine Research Unit staff who contributed to this work…

Introduction In cholera endemic areas, the periodicity of cholera outbreaks remains unpredictable,
making it difficult to organize preventive efforts. Lack of data on duration of protection …

The global nonprofit organization PATH hosted the third Vaccines Against Shigella and
Enterotoxigenic Escherichia coli (VASE) Conference in Washington, DC, on November 29 to …